Skip to main content

Table 6 Correlation between tumor SULpeak and PET-based therapeutic response in the study population

From: Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma

 Objective response by PERCISTTest value#P valueSig.
CMRPMRSMDPMD
No. = 18No. = 9No. = 2No. = 4
Base SULpeak
 Median (IQR)9.1 (4.7–14)12.3 (7.3–16)12.75 (5.5–20)10.4 (6.15–12)1.1850.757NS
 Range2–29.34.7–21.75.5–203.5–12
End SULpeak
 Median (IQR)0 (0–0)2.8 (2.6–3.7)13.64 (6.28–21)3.47 (1.32–5.45)24.0850.000HS
 Range0–1.42.2–8.96.28–210–6.6
Uptake reduction (%)
 Median (IQR)100 (100–100)56 (44–75)0 (0–0)54.5 (34.5–82)27.3100.000HS
 Range100–10037–890–024–100
  1. P value > 0.05 Non significant (NS), P value < 0.05 Significant (S), P value < 0.01 Highly significant (HS)
  2. # Kruskal–Wallis test